Hepatic Sarcoidosis with Abdominal Pain or Fever — When Corticosteroid Therapy Has Not Improved Liver Function

Clinical Scenario

This protocol applies to patients with hepatic sarcoidosis who are symptomatic — presenting with abdominal pain, fever, fatigue, or other constitutional symptoms — or who have significant liver function abnormalities with abnormal bilirubin or prothrombin time.

Previous Treatment & Reason for Escalation

These patients have already received Prednisone as first-line therapy. Despite this corticosteroid course, the expected goal of improved liver function tests was not achieved. This protocol defines the structured next step taken after that failure.

Next-Line Approach (Partial)

When an inadequate response to corticosteroids is established, the approach involves adding a cytotoxic agent. The specific options, selection criteria, and management algorithm are contained in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

Granulomatous hepatitis is usually treated in individuals with symptomatic liver disease, such as those with abdominal pain or jaundice with evidence of cholestasis, or if there are significant abnormalities in liver function, or even frank cirrhosis, demonstrated with increased PT.
When an inadequate response to corticosteroids is noted, cytotoxic agents are often used.
Most experience has been with azathioprine for hepatic sarcoidosis.

View source ↗